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Abstract
Background:  In 1995, Taiwan has launched a national health-care system (the National Health Insurance
Program, NHI) covering the use of both Western medicine (WM) and Chinese medicine (CM). This population-
based study was conducted to understand the role of CM in this dual medical system by determining the utilization
patterns of CM and WM and to analyze the demographic characteristics and primary indications influencing the
choice of the medical services for the development of strategies to enhance the appropriate use and reduce
unnecessary use of CM.
Methods: This study used the NHI sample files from 1997 to 2003 consisting of comprehensive utilization and
enrolment information for a random sample of 200,432 NHI beneficiaries of the total enrolees from 1995 to 2000.
A total of 136,720 subjects with valid and complete enrolment and utilization data were included in this study.
The logistic regression method was employed to estimate the odds ratios (ORs) for utilization of CM and WM.
The usage, frequency of services, and primary indications for CM and WM were evaluated. A significance level of
α = 0.05 was selected.
Results: Compared with WM, the odds of CM increased from 1997 to 2003. The odds of using CM (OR = 1.48;
95% CI: 1.45–1.50; p < 0.001) and WM (OR = 1.74; 95% CI: 1.72–1.77; p < 0.001) were higher in females and that
of CM increased with age to a peak in the 45–54-year-group (OR = 1.75; 95% CI: 1.68–1.82; p < 0.001) and WM
(OR = 1.09; 95% CI: 1.05–1.13; p < 0.001) in the elderly subjects (≥ 65 years). The odds of CM and WM were
similar in all income groups. However, those of CM were higher in Central (OR = 1.65; 95% CI: 1.56–1.74; p <
0.001) and Southern Taiwan (OR = 1.18; 95% CI: 1.12–1.25; p < 0.001) and lower in the remote areas (OR =
0.57; 95% CI: 0.52–0.63; p < 0.001). Most of the patients had one ambulatory visit of both medical services
annually. However, the utilization of WM predominated over CM. Over 90% of CM service was provided by
clinics, whereas over 60% of WM service by hospitals. Diseases of the respiratory system was the most frequent
primary indication in CM and WM. Herbal medication was the most commonly used form of CM (68.4–72.7%).
Conclusion: In recent years, there is an increasing trend in the utilization of CM in Taiwan. This increasing trend
may be due to the covering of CM in the national health insurance system.
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Background
There is an increasing trend in the utilization of comple-
mentary or alternative medicine (CAM) worldwide [1].
According to the estimation of the World Health Organi-
zation, the usage of CAM ranges from 9 to 65% in differ-
ent countries [2]. In the United States, CAM utilization
increased from 34% in 1990 to 42% in 1997 [3,4]. CAM
is also very popular in Europe [5], Canada [6], and Aus-
tralia [7]. Patients choosing CAM are not necessarily dis-
satisfied with conventional medical care. They are seeking
more effective ways to improve their health and well-
being and to relieve symptoms associated with chronic,
even terminal, illnesses or the side effects of conventional
treatments for them [8].
Among different forms of CAM, Chinese medicine (CM)
is well known for the medicinal formulas and acupunc-
ture, and is one of the most popular alternative medicines
in many countries. In Singapore, CM is the most popular
form of CAM and has been employed by 88% of the CAM
users [9]. Moreover, CM accounts for 40% of the health
care in China [10]. Although CM is commonly used in the
countries of East Asia, this system of medical service is also
growing in popularity and offers an important alternative
or complement to biomedical care in the Western coun-
tries [11].
In Taiwan, one distinguishing feature of the national
health-care insurance system is the co-existence of the
modern Western medicine (WM) and CM. In addition,
the social health-care insurance system covers CM since
1975. Although only bone fractures and dislocations were
included in the initial coverage of the Labor Medical
Insurance, the therapeutic items were then expanded to
internal medicine, gynecology, and acupuncture in 1983.
In 1988, the Public Employee Medical Insurance Program
started to reimburse CM [12]. After the implementation of
the National Health Insurance (NHI) Program in March
1995, all citizens who have established a registered dom-
icile in Taiwan are mandated to join the program. In June
2003, more than 99% of the 23-million population has
benefited from this universal health insurance program.
However, CM has only 5% of the total expenditure in the
NHI coverage. The health care items covered physician
consultation for diagnosis, drug prescription, acupunc-
ture, and muscle strain therapy [13].
Although information on different aspects of CM in Tai-
wan is available [12,14-18], these reports were based on
small samples [12,14-16] or limited to one component of
CM [17,18]. Moreover, some of these studies were con-
ducted before the establishment of the NHI program
[12,14,15]. Recently, a study on the use frequencies, char-
acteristics of users, and the disease categories treated by
CM in Taiwan was conducted based on the complete data-
sets of CM outpatient reimbursement claims from 1996 to
2001 [19]. However, except sex and age, other user char-
acteristics were not analyzed and the utilization pattern of
WM was only slightly explored. The purpose of this study
is to gain a more complete picture of utilization of CM in
the national health insurance system with dual medical
systems (Western and Chinese medical services) by deter-
mining the extent of CM utilization from 1997 to 2003
using WM as a reference and the demographic factors and
primary indications that predict the choice of the type of
medical service.
Methods
Data Resource
Since all citizens in Taiwan who have established a regis-
tered domicile should be enrolled in the NHI Program,
the NHI Bureau has accumulated 23.75 million adminis-
trative and claims records, forming the largest such collec-
tion in the world. The NHI research database was
established under the cooperation of National Health
Research Institutes (NHRI) and the NHI Bureau [13]. The
NHRI safeguards the privacy and confidentiality of the
subjects [20]. The database includes the NHI claims data
and data from the enrolment and provider files. In addi-
tion to birth date and sex of each patient, the NHI claims
data also record diagnosis, date of service, drugs pre-
scribed and filed, dispensing method and anonymous
identifiers for the patient, the hospital/clinic and the phy-
sician providing the service. All the individuals included
in the entire claims database (the general population)
were given different random numbers by using a random
number function. Simple random sampling of about
50,000 people at a time was performed in 2000. This sam-
pling database consisted of four simple randomly sam-
pled subsets and finally included 200,432 enrolees and
represents 1% of the total NHI beneficiaries. [20,21].
Study Sample
In this study, a nationally representative sample of
200,432 NHI enrollees was used. To construct a fixed
cohort, we excluded those who were newborns aged
below 2 years (5.0%) in 1997, died during the study
period (3.4%), were foreigners (4.1%), had incomplete
data (1.0%), and had no continuous enrollment informa-
tion from 1997 to 2003 (18.2%) sequentially. The final
fixed cohort consisted of 136,720 individuals. These indi-
viduals were observed to investigate the longitudinal uti-
lization patterns of CM and WM from 1997 to 2003.
Study variables
In order to understand the common factors affecting the
utilization of CM and WM, we selected the demographic
factors according to previous studies [12,22,23]. In addi-
tion to gender, ages were categorized into eight groups: 2–
7, 8–14, 15–24, 25–34, 35–44, 45–54, 55–64 and 65BMC Health Services Research 2008, 8:170 http://www.biomedcentral.com/1472-6963/8/170
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years or older. For the socio-economic status (SES), we
classified those with a well-defined monthly wage into
three categories: ≥ US$1,280, US$640–1,279 and <
US$640. Those people without a well-defined monthly
wage were categorized into two groups: farmers and fish-
ermen, and others, which include veterans, low-income
people and individuals enrolled in the NHI through local
government offices. Severe diseases were defined accord-
ing to the Illness and Injury Severity Score and the NHI
has an official list of major diseases including cancer,
acquired immune deficiency syndrome, major psychiatric
disorder, and so on [13]. Remote areas were defined offi-
cially according to mountainous geographic environment
and traffic conditions. There are 30 mountainous regions
proclaimed remote areas [21]. In addition, offshore
islands include Lanyu Isles, Green Island, and Penghu
Islands. These remote areas have been under-served with
insufficient medical services.
Definition of CM
In this study, CM is used pragmatically to refer to diagnos-
tic and therapeutic practices, including primarily herbal
medication, acupuncture, and muscle strain therapy. Mus-
cle strain therapy includes professional massage and oste-
opathy manual therapy. In this study, we also considered
dislocation treatment as one component of the muscle
strain therapy. These three components of CM are also
modalities of CAM defined in the Western countries [3].
In addition to these three main components, CM users
may also consult the physician only for physical examina-
tion or suggestion of management of the health care prob-
lems but without treatment. Consultation services were
also covered by the NHI Program.
Statistical analysis
The unit of observation was each individual in the study
sample. The usage, frequency of services, and primary
indications for CM and WM were evaluated. The classifi-
cation of primary indications was according to the Inter-
national Classification of Diseases Ninth Clinical
Modification (ICD-9-CM) [25]. The statistical software
SAS 9.13 [26] was used for data management and analy-
ses. A logistic regression model was used to analyze the
data, and generalized estimating equations were used to
account for correlation among the repeated measure-
ments [27,28]. Based on the correlation matrices of CM
and WM utilizations over time, an unstructured working
correlation was selected. In addition, sensitivity analyses
were conducted for autoregressive, independent and com-
pound symmetry, and the results remained robust. A sig-
nificance level of α = 0.05 was selected.
Results
Table 1 shows the demographic characteristics of the stud-
ied cohort. Adjusted ORs and 95% confidence intervals
(95% CIs) resulting from the logistic regression model are
displayed in Table 2. The odds of using CM (OR 1.48) and
WM (OR 1.74) were higher for females than for males
(OR 1.00). Compared with the youngest age group (OR
1.00), the odds of CM increased with age to a peak in the
45–54-year-group (OR 1.75) whereas those of WM
became relatively high only in the elderly subjects (≥ 65
years) (OR 1.09).
The odds of CM (OR 1.05) and WM (OR 1.00) in the
group with a monthly wage US$640-1,279 were higher
than those in the low-income group (< US$640) (CM: OR
1.04; WM: OR 0.98), farmers and fishermen (CM: OR:
0.90; WM: OR 0.97) and the other group (CM: OR 0.86;
WM: OR: 0.77). Although the odds of CM were similar in
the groups with (OR 1.00) and without (OR 1.00) severe
diseases, the odds of WM in the people with severe dis-
eases (OR 2.40) was higher than those without these dis-
eases (OR 1.00) (Table 2).
Table 1: Demographic characteristics of the studied cohort (n = 
136,720)
Characteristic* No. of subjects %
Gender
Male 68,135 49.8
Female 68,585 50.2
Age (years)
2–7 9,648 7.1
8–14 11,933 8.7
15–24 23,244 17.0
25–34 26,903 19.7
35–44 27,307 20.0
45–54 17,273 12.6
55–64 9,986 7.3
≥ 65 10,426 7.6
Socio-economic status
< US$640 54,729 40.0
US$640-1279 29,788 21.8
≥ US$1280 11,137 8.1
Farmers and fishermen 21,568 15.8
Others 19,498 14.3
Severe disease
Without 132,835 97.2
With 3,885 2.8
Region
Taipei 43,392 31.7
Northern Taiwan 18,830 13.8
Central Taiwan 26,732 19.6
Southern Taiwan 21,241 15.5
Kaohsiung and Pingtung 22,848 16.7
East Taiwan 3,677 2.7
Remote Area
Mountainous regions 1,159 0.9
Offshore islands 1,156 0.9
General Population 134,405 98.2
*Determined from 1997 prospectively.BMC Health Services Research 2008, 8:170 http://www.biomedcentral.com/1472-6963/8/170
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The odds of CM were higher among people in Central
(OR 1.65), Southern (OR 1.18), and Kaohsiung and Ping-
tung (OR 1.09) than those in Eastern Taiwan (OR 1.00),
Northern Taiwan (OR 0.96), and Taipei (OR 0.91). How-
ever, those of WM were higher among people in Taipei
(OR 1.03), Northern Taiwan (OR 1.08), Central Taiwan
(OR 1.15), Southern Taiwan (OR 1.20), and Kaohsiung
and Pingtung (OR 1.21) than Eastern Taiwan (OR 1.00).
The odds of CM in the general population (OR 1.00) was
higher than those in the mountainous regions (OR 0.57)
and offshore islands (OR 0.78) whereas those of WM were
higher in mountainous regions (OR 1.03) and offshore
islands (OR 1.21) than the general population (OR 1.00)
(Table 2).
Table 2 also shows a steady increasing trend in the odds of
CM from 1997 (OR 1.00) to 2003 (OR 1.15). Moreover,
the odds WM utilization also increased from 1997 (OR
Table 2: Adjusted odds ratios and 95% confidence intervals for characteristics associated with the utilization of Chinese medicine and 
Western medicine (n = 136,720)
Characteristic Chinese medicine p value Western medicine p value
Gender
Male 1.00 1.00
Female 1.48 (1.45–1.50)* < 0.001 1.74 (1.72–1.77) < 0.001
Age (years)
2–7 1.00 1.00
8–14 1.14 (1.10–1.18) < 0.001 0.50 (0.49–0.51) < 0.001
15–24 1.38 (1.33–1.44) < 0.001 0.36 (0.36–0.37) < 0.001
25–34 1.58 (1.52–1.64) < 0.001 0.38 (0.37–0.38) < 0.001
35–44 1.74 (1.67–1.81) < 0.001 0.39 (0.38–0.40) < 0.001
45–54 1.75 (1.68–1.82) < 0.001 0.45 (0.44–0.46) < 0.001
55–64 1.63 (1.56–1.71) < 0.001 0.64 (0.63–0.66) < 0.001
≥ 65 1.51 (1.44–1.58) < 0.001 1.09 (1.05–1.13) < 0.001
Socioeconomic status
≥ US$1,280 1.00 1.00
US$640-1,279 1.05 (1.03–1.07) < 0.001 1.00 (0.98–1.01) 0.473
< US$640 1.04 (1.02–1.06) < 0.001 0.98 (0.96–0.99) < 0.001
Farmers and fishermen 0.90 (0.87–0.92) < 0.001 0.97 (0.95–0.99) < 0.001
Others 0.86 (0.84–0.88) < 0.001 0.77 (0.76–0.78) < 0.001
Severe disease
Without 1.00 1.00
With 1.00 (0.95–1.05) 0.900 2.40 (2.29–2.52) < 0.001
Region
Eastern Taiwan 1.00 1.00
Taipei 0.91 (0.86–0.96) 0.001 1.03 (0.99–1.07) 0.117
Northern Taiwan 0.96 (0.90–1.01) 0.123 1.08 (1.04–1.13) < 0.001
Central Taiwan 1.65 (1.56–1.74) < 0.001 1.15 (1.11–1.20) < 0.001
Southern Taiwan 1.18 (1.12–1.25) < 0.001 1.20 (1.15–1.25) < 0.001
Kaohsiung and Pingtung 1.09 (1.03–1.16) 0.002 1.21 (1.16–1.26) < 0.001
Remote Area
General Population 1.00 1.00
Mountainous regions 0.57 (0.52–0.63) < 0.001 1.03 (0.96–1.11) 0.356
Offshore islands 0.78 (0.70–0.86) < 0.001 1.21 (1.13–1.30) < 0.001
Season
Winter (December – February) 1.00 1.00
Spring (March – May) 0.95 (0.95–0.96) < 0.001 0.88 (0.88–0.89) < 0.001
Summer (June – August) 0.90 (0.89–0.90) < 0.001 0.79 (0.79–0.80) < 0.001
Autumn (September – November) 0.93 (0.93–0.94) < 0.001 0.86 (0.85–0.86) < 0.001
Year
1997 1.00 1.00
1998 1.05 (1.03–1.06) < 0.001 1.10 (1.10–1.11) < 0.001
1999 1.10 (1.09–1.12) < 0.001 1.21 (1.20–1.22) < 0.001
2000 1.10 (1.09–1.11) < 0.001 1.26 (1.25–1.27) < 0.001
2001 1.11 (1.09–1.12) < 0.001 1.27 (1.26–1.28) < 0.001
2002 1.12 (1.10–1.13) < 0.001 1.28 (1.26–1.29) < 0.001
2003 1.15 (1.14–1.17) < 0.001 1.17 (1.16–1.19) < 0.001
*Odds ratio (95% confidence interval).BMC Health Services Research 2008, 8:170 http://www.biomedcentral.com/1472-6963/8/170
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1.00) to 2002 (OR 1.28) but decreased in 2003 (OR 1.17).
Of all seasons, the odds of either CM or WM were the
highest in winter.
The crude utilizations of CM and WM are shown in Table
3. The number of CM users increased from 36,372 in 1997
to 41,823 in 2003. However, the number of WM users
from 115,833 in 1997 to 121,605 in 2002 and decreased
to 120,926 in 2003. The average number of patients who
had used any CM service in one year and the number of
visits to CM providers were 39,562 and 191,612, respec-
tively. The corresponding figures for WM were 119,915
and 1,542,342. Most of the patients had one ambulatory
visit a year. However, the utilization frequency of WM
(mean = 12.55–13.34, median = 8–9) was higher than
that of CM (mean = 4.63–5.03, median = 2–3). Most of
the ambulatory CM service was provided by clinics (93.4–
96.1%) and only 3.9–6.6% was provided by hospitals.
Moreover, the frequency of ambulatory visits in hospitals
steadily increased from 3.9% in 1997 to 6.6% in 2002. On
the other hand, clinics provided about two-thirds (60.5–
67.8%) of the ambulatory WM service, outpatient depart-
ment of the hospitals took the remaining one-third (32.2–
39.5%) of ambulatory service.
Diseases of the respiratory system (CM 22.1%, WM
35.6%) and the musculoskeletal system and connective
tissue (CM 18.1%, WM 7.5%) were the top two primary
indications in the ambulatory health care of both CM and
WM. In CM, the remaining common primary indications
were injury and poisoning (16.2%), diseases of signs,
symptoms and ill-defined conditions (14.2%), and dis-
eases of the digestive system (11.4%). In WM, diseases of
the genitourinary system (7.2%), diseases of the digestive
system (7.2%), and diseases of sense organs (7.1%) were
also common primary indications (Table 4).
Herbal medication was the most important component of
CM. This component accounted for more than two-thirds
of the ambulatory visits (68.4–72.7%). The utilization
rate decreased from 70.8% in 1997 to 68.7% in 2003. The
other two major components were muscle strain therapy
(including dislocation therapy) and acupuncture. Muscle
strain therapy accounted for 15.6–17.5% and acupunc-
ture for 9.2–13.0% of the ambulatory visits. These two
components showed increasing utilization trends: muscle
strain therapy increased from 16.4% in 1997 to 17.2% in
2003 and acupuncture from 9.4% in 1997 to 13.0% in
2003. In addition to these main components of CM, gen-
eral consultation services accounted for 3.4% in 1997.
However, the utilization of these consultation only serv-
ices decreased to 1.1% in 2003 (Table 5).
Discussion
In this study, the logistic regression method was used to
identify patient characteristics associated with the utiliza-
tion patterns of CM and WM over time. Females used
both health care services more than males. The higher uti-
lization of CM in females has also been reported in Singa-
pore [9] and the Western countries [11,29-32] as well as
in Taiwan [12,14,16,19]. In practice, CAM has been used
to treat postpartum conditions, menopause, and chronic
diseases among women [16,19,29,32-35]. Moreover, the
age distribution of CM utilization peaked at 45–54 years.
This finding is similar to those reported previously
[11,12,16,19,29-32]. Since WM provides health-care serv-
ices such as vaccinations for the children [36], the utiliza-
tion was revealed to increase with age and peak in
Table 3: Crude utilizations of Chinese and Western medicine under the NHI program, 1997–2003 (total population = 136,720)
Frequency of utilization Provider
Year No. of users No. of visits Mean ± SD Median Mode Hospital (%) Clinic (%)
Chinese medicine
1997 36,372 181,109 4.98 ± 6.59 3 1 7,060 (3.9) 174,049 (96.1)
1998 37,622 189,330 5.03 ± 6.60 3 1 7,709 (4.1) 181,621 (95.9)
1999 39,635 196,908 4.97 ± 6.36 3 1 9,461 (4.8) 187,447 (95.2)
2000 40,227 188,713 4.69 ± 5.81 2 1 10,330 (5.5) 178,383 (94.5)
2001 40,425 187,198 4.63 ± 5.73 3 1 10,865 (5.8) 176,333 (94.2)
2002 40,833 191,251 4.68 ± 5.82 3 1 12,617 (6.6) 178,634 (93.4)
2003 41,823 206,777 4.94 ± 6.45 3 1 11,497 (5.6) 195,280 (94.4)
Western medicine
1997 115,833 1,486,570 12.83 ± 13.82 8 1 478,493 (32.2) 1,008,077 (67.8)
1998 118,504 1,553,383 13.11 ± 14.07 9 1 509,743 (32.8) 1,043,640 (67.2)
1999 120,362 1,606,111 13.34 ± 13.85 9 1 549,420 (34.2) 1,056,691 (65.8)
2000 120,982 1,552,771 12.83 ± 12.92 9 1 554,656 (35.7) 998,115 (64.3)
2001 121,190 1,533,878 12.66 ± 12.97 9 1 583,055 (38.0) 950,823 (62.0)
2002 121,605 1,545,956 12.71 ± 13.23 9 1 610,399 (39.5) 935,557 (60.5)
2003 120,926 1,517,722 12.55 ± 13.69 8 1 568,128 (37.4) 949,594 (62.6)BMC Health Services Research 2008, 8:170 http://www.biomedcentral.com/1472-6963/8/170
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youngest group (2–7 years). Moreover, WM utilization
was highest in the elderly people (≥ 65 years).
The utilization of CM was higher in the regular salary
income group than the low-income group, farmers and
fishermen and the other group. These results are similar to
the previous findings that CAM users are those with
higher education and in the middle to upper socioeco-
nomic status [3,4,37,38]. WM was more frequently used
by patients with severe diseases. These diseases require
long-term supportive treatment and may not be suitable
for CM. Although CM usage was more prevalent in the
central and southern parts of Taiwan, CM was not fre-
quently used in mountainous areas and offshore islands.
One possible explanation for this phenomenon is the
uneven distribution of CM providers, since there are only
6 CM hospitals and 24 CM clinics in eastern Taiwan [13].
In a previous study, 62.5% of the valid beneficiaries in the
NHI Program have been reported to use CM at least once
from 1996 to 2001 [19]. By controlling the co-variant fac-
tors, we found an increasing trend in the utilization of CM
and WM. Moreover, 39,562 patients used CM services in
each year whereas the corresponding figures for WM were
119,915. Most of patients had a single ambulatory visit
annually. However, the mean utilization frequency of
WM (12.55–13.34) was higher than that of CM (4.63–
5.03). The numbers reported in this study may seem
higher than those reported previously [19] because these
values were based on only users, not total population. In
addition, we revealed that over 90% of the CM services
Table 4: Primary indications in ambulatory visits of Chinese and Western medicine under the National Health Insurance Program in 
Taiwan from 1997 to 2003
Primary indication (ICD-9-CM code)
Chinese medicine 
(n=1,341,286)
Western medicine
(n=10,796,391)
1 Infectious and parasitic diseases 0.5* 2.3
2 Malignant neoplasms 0.2 0.7
3 Other neoplasms 0.1 0.7
4 Endocrine, nutritional and metabolic diseases and immunity disorders 1.3 3.8
5 Mental disorders 0.6 2.0
6 Diseases of the nervous system 1.6 1.3
7 Diseases of the sense organs 1.2 7.1
8 Diseases of the circulatory system 1.8 6.3
9 Diseases of the respiratory system 22.1 35.6
10 Diseases of the digestive system 11.4 7.2
11 Diseases of the genitourinary system 7.2 7.2
12 Complications of pregnancy, childbirth and the puerperium 0.1 0.4
13 Diseases of skin and subcutaneous tissue 3.1 6.2
14 Diseases of the musculoskeletal system and connective tissue 18.1 7.5
15 Congenital anomalies 0.1 0.1
16 Certain conditions originating in the perinatal period 0.0 0.0
17 Signs, symptoms and ill-defined conditions 14.2 3.7
18 Injury and poisoning 16.2 4.5
19 Accidents and self inflicted injury 0.0 0.1
20 Other reasons for contact with health services 0.2 3.3
*%.
Table 5: Percentage distribution of ambulatory visits for different components of Chinese medicine under the National Health 
Insurance Program in Taiwan from 1997 to 2003
Year
Component* 1997 1998 1999 2000 2001 2002 2003
Herbal medication 70.8 72.7 71.8 70.5 69.3 68.4 68.7
Muscle strain therapy (Inc l u d i n g  d i s l o c a t i o n  t h e r a p y ) 1 6 . 41 5 . 61 5 . 61 6 . 01 6 . 61 7 . 51 7 . 2
Acupuncture 9.4 9.2 10.0 11.5 12.1 12.9 13.0
Consultation only and others 3.4 2.5 2.6 2.0 2.0 1.2 1.1
Total 179,464 205,637 221,440 206,108 208,487 210,720 225,705
*More than one component may be provided in each visit.BMC Health Services Research 2008, 8:170 http://www.biomedcentral.com/1472-6963/8/170
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were provided by clinics whereas clinics only provided
about two-thirds (60.5–67.8%) of the ambulatory WM
services. These findings were consistent with those
reported previously [15,19,39]. Under the NHI Program,
copayments vary with the provider type. They are highest
for ambulatory health care at medical centres and lowest
for clinics [40]. Moreover, the copayments in CM are
lower than WM. Therefore, more than 90% of the CM
users visited clinics and less than 10% CM hospitals.
Based on the ICD-9-CM code, we found that diseases of
the respiratory system, diseases of the musculoskeletal
system and connective tissue, injury and poisoning, signs,
symptoms and ill-defined conditions, and diseases of the
digestive system were the primary indications in CM. Sim-
ilar patterns have been reported previously [12,14]. How-
ever, the top two primary indications were also the same
as those in WM. We have also found that the utilization of
these two health-care services was higher in winter than in
the remaining seasons. These findings may be due to the
fact that diseases of the respiratory system occurs more fre-
quency in winter. These findings indicate that CM may be
a feasible complementary choice for the patients with res-
piratory diseases.
Herbal medication is the major component of CM
accounting for more than two-thirds of the ambulatory
visits. In the United States, herbal products have an
annual market of US$5.1 billion [41] and 38.2 million
adults have used herbs and supplements [42]. The herbal
prescriptions in the Western countries are usually with a
single herb whereas the majority of prescriptions in Tai-
wan are composed of 3–6 herbs and are often prescribed
for three times a day [17]. Under the NHI program, herbal
formulas were provided as standard pharmaceutical prod-
ucts in standard powder forms. This strategy not only can
control the quality of the prescriptions but also enable the
standardization of herbal formulas. Acupuncture is
another popular form of CAM [3-7]. It is mainly
employed in the treatment of neurologic and muscu-
loskeletal diseases [18,43,44]. In Taiwan, about 23% of
people used acupuncture from 1996 to 2002 [18]. We
obtained similar results in this study. In addition to an
increasing trend in the utilization of acupuncture, the
prevalence of muscle strain therapy was also increased in
recent years. This increase may be due to the increase in
the number of providers [13]. However, further investiga-
tions are needed to confirm this suggestion.
This study is the first population-based investigation to
determine the utilization patterns of CM and WM in Tai-
wan under the NHI Program. Since we obtained the data
from a sufficiently large national representative sample
from the NHI sample files, some of the common short-
comings in interview or questionnaire surveys may be
avoided. The large sample size and the comprehensive
datasets allow us to study a wide array of factors in the
general population. However, we have excluded enrolees
who were newborns aged below 2 years in 1997, those
died in the study period, aliens, those with incomplete
data, and those without continuous enrolment informa-
tion. This manipulation of the data may lead to some
selection bias. Since we used only the NHI claims data, we
are unable to determine the utilization of CM services not
covered by the NHI program. Therefore, the utilization of
CM in Taiwan might be underestimated.
Conclusion
The utilization of CAM has rapidly increased in many
countries during the last two decades [4-7]. CAM is rarely
covered in national health systems. However, 75% of the
Dutch population wanted hospitals to provide CAM [45]
and 74% of the people in UK felt that complementary
therapies should be available on the national health sys-
tem [46]. In Taiwan, the NHI Program is a comprehensive
and universal health insurance program. This program
not only covers conventional WM services, but also tradi-
tional CM services. Moreover, CM is popular and more
than 60% of all beneficiaries of this health insurance sys-
tem had used CM at least once a year [19]. In this study,
we found that the rate of increase in the use of CM was
smaller than that in WM (Table 2) and that the increase
was not apparently shown in the number of visits per user.
Taiwan's experience of covering CM services under its
national health insurance system may serve as an impor-
tant reference to other countries. This strategy offers peo-
ple another choice for medical care services with
mandated coverage.
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